Genesys Capital
Toronto, Ontario
Investment Thesis
Genesys invests in early-stage life science companies addressing unmet medical needs, leveraging 25+ years of immersion in Canada's most productive research corridor. The fund employs a company co-creation strategy, working closely with local scientific founders as thought partners to build pioneering healthcare companies. Deep partnerships with leading North American research institutes provide early access to top-tier discoveries and differentiated deal flow.
Focus Areas
Investment Stage
Early
Sectors
Investment Signals
GeographyCanada-focused
ProvincesON, QC
RoleLead
Revenue Stagepre-revenue ok
Impact MandateYes
Business Modelsdeep-tech, IP-licensing
Sample Portfolio Companies
Fusion Pharmaceuticals
Feldan Therapeutics
Inversago Pharma
CryoStasis Inc
Epocal
Questat
Management Team
G
Genesys team - Canada's longest standing life sciences partnership
What Makes Us Unique
25 years building world-class life science companies. Deep network of repeat founders. Trusted source of deal flow for US, European, strategic investors.
AUM & Sources
Est. US$400M
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.